Are you Dr. Nathan?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 23 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
Harvard Med Sch
Boston, MA 02115
Summary
- Dr. Carl Nathan, MD is an allergist/immunologist in Boston, Massachusetts. He is currently licensed to practice medicine in New York.
Education & Training
Harvard Medical SchoolClass of 1972
Certifications & Licensure
NY State Medical License 1979 - 2020- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Elected Member Institute of Medicine, 1998
Clinical Trials
- A 14 Day Early Bactericidal Activity Study of Nitazoxanide for the Treatment of Tuberculosis Start of enrollment: 2016 Feb 01
Publications & Presentations
PubMed
- 80 citationsIn vitro differentiation of human macrophages with enhanced antimycobacterial activityGuillaume Vogt, Carl Nathan
The Journal of Clinical Investigation. 2011-10-03 - 31 citationsFatal Cytomegalovirus Infection in an Adult with Inherited NOS2 DeficiencyScott Drutman, Davood Mansouri, Seyed Alireza Mahdaviani, Anna-Lena Neehus, David Hum
The New England Journal of Medicine. 2020-01-29 - 1465 citationsIdentification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity.Carl Nathan, Henry W. Murray, M E Wiebe, Berish Y. Rubin
The Journal of Experimental Medicine. 1983-09-01
Press Mentions
Eli Lilly-Backed IpiNovyx Bio Emerges with $10M for 2023 Clinical EntryOctober 5th, 2021- Weill Cornell Advances TB Research with Support from NIHSeptember 3rd, 2021
- Commentary: Multisector Research Collaborative Aims to Advance Tuberculosis TreatmentAugust 4th, 2021
- Join now to see all
Grant Support
- Biology Of Lipoamide Dehydrogenase And 2-Hydroxy-3-Oxoadipate Synthase In MTBNational Institute Of Allergy And Infectious Diseases2011–2012
- Mycobacterial Proteasome InhibitorsNational Institute Of Allergy And Infectious Diseases2009–2010
- Targets In Mycobacterium Tuberculosis: Stress Resistance &RepairNational Institute Of Allergy And Infectious Diseases2007–2009
- Macrophages, Dendritic Cells And PathogensNational Institute Of Allergy And Infectious Diseases2003–2007
- Targets In M. Tuberculosis:Stress Resistance &RepairNational Institute Of Allergy And Infectious Diseases2005–2006
- Dihydrolipoamide Acyltransferase:Target For ChemotherapyNational Institute Of Allergy And Infectious Diseases2004
- Targeting Defenses Of Mycobacterium TuberculosisNational Heart, Lung, And Blood Institute2002–2004
- Role Of NO Synthase-2 In Murine Alzheimer'S DiseaseNational Institute On Aging2000–2004
- Neutrophil Activation In Sepsis-- Role Of PYK2 PathwayNational Institute Of Allergy And Infectious Diseases2000–2004
- Mycobacterial Resistance To Reactive Nitrogen/OxygenNational Heart, Lung, And Blood Institute1999–2003
- Septic Shock In Nitric Oxide Synthase Deficient MiceNational Institute Of General Medical Sciences1996–1999
- Nitric Oxide In Anti-Tuberculous Defense Of The LungNational Heart, Lung, And Blood Institute1996–1997
- General Clinical Research CenterNational Center For Research Resources1996–1997
- Regulation Of Nitric Oxide Synthase In MacrophagesNational Institute Of Allergy And Infectious Diseases1993–1997
- General Clinical Research CenterNational Center For Research Resources1996
- Adhesion-Dependent Neutrophil Respiratory BurstNational Cancer Institute1992–1996
- Macrophage DeactivationNational Cancer Institute1991–1995
- Gordon Conference On PhagocytesNational Institute Of Allergy And Infectious Diseases1993
- Short Term Training In The Health ProfessionsNational Institute Of General Medical Sciences1991–1992
- Oxidative Injury By Human NeutrophilsNational Cancer Institute1987–1991
- Biochemistry Of Cytotoxicity Of Phagocytes &LymphocytesNational Cancer Institute1988–1990
- Biochemical Bases Of Cytotoxicity By Phagocytes And LympNational Cancer Institute1985–1987
- Pharmacologic Subversion Of The Antioxidant Defenses Of Human TumorsNational Cancer Institute1985–1986
- Biochemical Bases Of Cytotoxicity By Phagocytes And LympNational Cancer Institute1985
